The effect of antibiotics with potential antiviral and anti-inflammatory properties are being investigated in clinical trials as a treatment for COVID-19. The use of antibiotics follows the intention to treat the viral disease and not primarily to treat bacterial co-infections of individuals with COVID-19. A thorough understanding of the current evidence regarding the effectiveness and safety of antibiotics as anti-viral treatments for COVID-19 is required.
Dr. KK Aggarwal
President Heart Care Foundation of India and Group Editor in Chief MEDtalks
Dr. Jamal Uddin Chowdhury
Senior Central Executive Committee Member, Bangladesh Medical Association
Dr. Sundaram Arulrhaj
Founder & Chairman of Commonwealth Medical Association Trust 2013 onwards